By Dr. Nick van Terheyden – Years ago, I was driving across states with a good friend and colleague from Spain. We stopped in at a gas station that had a Subway restaurant on the side. When my Spanish colleague was asked if he wanted his sandwich “To Go,” he looked at me quizzically and asked what they meant (he spoke excellent English).
Read More
By Thomas Kluz – The discovery of Yamanaka factors by Nobel laureate Shinya Yamanaka, which can reprogram adult cells into induced pluripotent stem cells, ignited serious scientific interest in whether aging might be partially reversible.
By Ben Hilmes – ViVE has become one of those industry gatherings where real conversations happen. Leaders from across healthcare come together to showcase ideas and pressure-test them. I attended this year with a clear intention: to be present where systems-level change is discussed, and to engage in those conversations in a realistic, accountable way.
By David Pessis – After years with two influential technology organizations, working at the intersection of large-scale systems, product strategy, and engineering execution, I learned that AI innovation moves fastest and delivers the most value when product and engineering operate as a single, unified organization.
By Ben Crocker MD – The debate over the return on investment (ROI) of ambient AI clinical documentation has reached a critical juncture. What began as a narrow question – Do AI scribes increase productivity enough to justify their cost? – has turned into something more revealing: a broader reckoning with how health systems define value in the clinical AI era.
Newly released episode of AI Amplified. Host Dr. Heather Bassett talks to Dr. Erin Palm, Medical Lead at Infinitus Systems Inc., trauma surgeon, and clinical assistant professor of surgery at Stanford University School of Medicine.
By Andy Flanagan – Behavioral health providers are treating more patients than ever while operating in three overlapping zones of regulatory uncertainty. DEA prescribing flexibilities expire and get extended at the last minute, again. Telehealth reimbursement parity loses enforcement teeth even as virtual care becomes standard practice.
By Quentin Chu – OpenAI’s entry into healthcare is good news, unambiguously. When the company behind ChatGPT announces a dedicated health product, it validates what many of us have known: AI has crossed the threshold of genuine clinical utility. Patient expectations are shifting. Health systems are finally ready to engage seriously with AI. The consumer health moment is real and worth celebrating.
Newly released episode of AI Amplified. Host Dr. Heather Bassett talks to Ronald Rodriguez MD PhD, a professor of medical education and program director for the MD/MS in Artificial Intelligence dual degree at the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas at San Antonio.